NCT06670170View on ClinicalTrials.gov

A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 5, 2024

Primary Completion Date

December 24, 2024

Study Completion Date

January 17, 2025

Conditions
Healthy Volunteers
Interventions
DRUG

PF-07976016 Formulation A

PF-07976016; formulation A - current/reference

DRUG

PF-07976016 Formulation B

PF-07976016; Formulation B - new/test

Trial Locations (1)

06511

Pfizer Clinical Research Unit - New Haven, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT06670170 - A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy Adults | Biotech Hunter | Biotech Hunter